(Q37820985)

23 August 2017

1 reference

title

The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia (English)

1 reference

23 August 2017

0 references

1

0 references

Basant K Puri

object named as

Basant K Puri

5

0 references

author name string

Neva H Patel

2

1 reference

23 August 2017

Kuldip S Nijran

3

1 reference

23 August 2017

Adil Al-Nahhas

4

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

37-51

1 reference

1999 ICP Distinguished Scientist Award. The history of positron emission tomography

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Amygdalar and hippocampal substrates of anxious temperament differ in their heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Medial prefrontal default-mode hypoactivity affecting trait physical anhedonia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Raclopride, a new selective ligand for the dopamine-D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Relative glucose metabolic rate higher in white matter in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Long-term stability of measuring D(2) receptors in schizophrenia patients treated with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

General and specific cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Positron emission tomography in schizophrenia: a new perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Origins of spatial working memory deficits in schizophrenia: an event-related FMRI and near-infrared spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Sequential neural changes during motor learning in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

A continuous emotional task activates the left amygdala in healthy volunteers: (18)FDG PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Neurocognitive performance and functional disability in the psychosis prodrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: longitudinal positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Evaluative processing of ambivalent stimuli in patients with schizophrenia and depression: a [15O] H2O PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Neurocognitive allied phenotypes for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Novel drug interactions at D(2) dopamine receptors: modulation of [3H]quinpirole binding by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Insights into schizophrenia using positron emission tomography: building the evidence and refining the focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.160

21 January 2018

Identifiers

DOI

10.1586/ERN.10.160

1 reference

23 August 2017

1 reference